Síguenos en Twitter     Síguenos en Facebook     Síguenos en YouTube     Siguenos en Linkedin     Correo Salutsantjoan     Gmail     Dropbox     Instagram     Google Drive     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon


My photo
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com




Monday, July 5, 2021

Nebulized Ketamine

REBEL EM - July 05, 2021 - By Salim Rezaie
Paper: Dove D et al. Comparison of Nebulized Ketamine at Three Different Dosing Regimens for Treating Painful Conditions in the Emergency Department: A Prospective, Randomized, Double-Blind Clinical Trial. Ann Emerg Med 2021. [Epub Ahead of Print]
Clinical Question: What is the analgesic effectiveness and safety of nebulized ketamine at 3 different doses for ED patients presenting with acute and chronic painful conditions?
Author Conclusion: “We found no difference between all 3 doses of ketamine administered through breath-actuated nebulizer for short-term treatment of moderate to severe pain in the emergency department.”
Clinical Take Home Point: 0.75mg/kg of nebulized ketamine was both efficacious and safe in the control of acute pain in the ED. Additionally, compared to previous evidence looking at IV sub-dissociative ketamine there appears to be a signal of decreased levels of psycho-perceptual effects and need for rescue analgesia. However, these last two findings would need to be studied in a trial comparing nebulized vs IV ketamine.